Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: A comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and β2-microglobulin

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1161-1167

  Stein, Daniel S ^a   Lyles, Robert H ^e   Graham, Neil M H ^b   Tassoni, Charles J ^c   Margolick, Joseph B ^e   Phair, John P ^e   Rinaldo, Charles ^e   Detels, Roger ^e   Saah, Alfred ^d   Bilello, John ^e  

^a ALBANY MEDICAL COLLEGE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; NEOPTERIN; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DEATH; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMBRANE BINDING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 16944362070     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514108     Document Type: Article

References (15)

1. Stein DS, Korvick JA, Vermund SH. CD4 lymphocyte cell enumeration for prediction of clinical course of HIV disease: a review. J Infect Dis 1992;165:352-63.
2. Graham NMH, Park LP, Piantadosi S, et al. Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy. Clin Infect Dis 1995;20:352-62.
3. Godfried MH, van der Poll T, Mulder JW, et al. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection. J Acquir Immune Defic Syndr 1995;10:531-9.
4. Godfried MH, van der Poll T, Weverling GJ, et al. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 1994; 169:739-45.
5. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
6. Welles SL, Jackson JB, Yen-Lieberman B, et al. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. J Infect Dis 1996;174:696-703.
7. Coombs RW, Welles SL, Hooper C, et al. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. J Infect Dis 1996;174:704-12.
8. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-10.
9. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-31.
10. Mayers DL, Saravolatz L, Winslow D, et al. Viral burden measurements in CPCRA 007 [abstract LB031]. In: Program and abstracts: XI International Conference on AIDS (Vancouver, Canada). Vancouver: XI International Conference on AIDS Society, 1996.
11. Hogervorst E, Jurriaans S, de Wolf F, et al. Predictors for non- and slow progression in human immunodeficiency (HIV) type 1 infection: low RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 1995;17:811-21.
12. Katzenstein DA, Hammer SM, Hughes MD, et al. The relationship of virologie and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996;335:1091-8.
13. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
14. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328:327-35.
15. Shattuck RJ, Rizzardi GP, Hayes P, Griffin GE. Engagement of adhesion molecules (CD18, CD11a, CD45, CD44, CD58) enhances human immunodeficiency virus type 1 replication in monocytic cells through a tumor necrosis factor-modulated pathway. J Infect Dis 1996:174:54-62.